Related Experiment Video

Updated: Dec 25, 2025

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

554

Mdr1 gene expression and mutations in Ras proto-oncogenes in acute myeloid leukemia

Markus Schaich1, Thomas Illmer

  • 1Department of Medicine I, University Hospital C.G. Carus, Dresden, Germany. schaich@mk1.med.tu-dresden.de

Leukemia & Lymphoma
|October 23, 2002
PubMed

Insights

Ras mutations negatively correlate with mdr1 expression in acute myeloid leukemia (AML), suggesting Ras signaling impacts P-glycoprotein (P-gp) activity and potentially treatment outcomes in AML patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Hematology

Background:

  • Resistance to cytotoxic therapy in acute myeloid leukemia (AML) is often linked to P-glycoprotein (P-gp) expression.
  • P-gp, encoded by the mdr1 gene, is a key factor in multidrug resistance.
  • Aberrant signaling pathways, including Ras activation, are implicated in modulating mdr1 expression.

Purpose of the Study:

  • To investigate the potential influence of Ras signaling on mdr1 expression in AML.
  • To explore the correlation between Ras mutations and mdr1 expression in AML blast samples.
  • To discuss the implications of Ras-mdr1 interactions on AML treatment outcomes.

Main Methods:

  • Analysis of Ras mutation status in AML patient samples.
  • Assessment of mdr1/P-gp expression levels in AML blast cells.
  • Correlation analysis between Ras mutations and mdr1 expression.

Main Results:

  • A negative correlation was observed between Ras mutations and mdr1 expression in AML blast samples.
  • This suggests that Ras activation may downregulate mdr1/P-gp expression.

Conclusions:

  • Ras mutations may play a role in modulating P-gp expression in AML.
  • Understanding the Ras-mdr1 axis could offer new therapeutic strategies for overcoming drug resistance in AML.
  • Further research is warranted to elucidate the precise mechanisms and clinical implications.

More Related Videos

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

7.9K
Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

10.3K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.9K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K